已收盤 09-20 16:00:00 美东时间
-0.110
-9.73%
Coherus Biosciences ( ($CHRS) ) has shared an update. The Company is addressing...
09-14 05:47
Coherus BioSciences Inc - Company Projects That These Actions Will Collectively...
09-14 05:34
Coherus BioSciences Inc - Projects Channel Supply Udenyca to Be Substantially D...
09-14 05:31
UBS has downgraded Coherus Biosciences (NASDAQ:CHRS) to neutral, citing limited growth opportunities. "Although CHRS has monetized assets to pay down debt, we believe the cash burn and leverage outloo...
08-17 04:32
Coherus BioSciences Inc : UBS Cuts to Neutral From Buy
08-16 22:00
Coherus BioSciences Inc : UBS Cuts Target Price to $1.5 From $4
08-16 22:00
Coherus BioSciences shares are trading higher after the company reported better...
08-09 05:19
Coherus Biosciences (CHRS) has shared an announcement. Bryan McMichael, previou...
08-09 04:58
Coherus BioSciences Inc: Bryan Mcmichael Appointed as Chief Financial Officer
08-09 04:38
Canadian drug developer Apotex on Tuesday announced an agreement with Coherus Biosciences (NASDAQ:CHRS) to buy Canadian rights to the former’s cancer therapy toripalimab, marketed in the U.S. as Loqto...
07-03 00:09